Healthcare Spending vs. Health Investment: A Growing Divide
A physician examines why insurers rarely invest in chronic illness prevention, citing a structural mismatch between spending and long-term savings.
A fundamental tension in the American healthcare system is drawing renewed scrutiny: insurers routinely pay for treatment but rarely invest in prevention, even when doing so could reduce costs significantly over time.
Russell Greenfield, MD, examines this disconnect in work released from Whittier, California, spotlighting a core dilemma — an insurer that funds a chronic illness prevention program may never recoup the savings if enrolled members switch plans before the financial benefits emerge. The incentive structure, in effect, penalizes long-term thinking.
Read more Pennsylvania Property Tax Rebate Program: Who Qualifies and How to Apply →
The problem reflects a broader misalignment baked into how health coverage is designed and priced in the United States. Because insurers compete for members year to year, the time horizon for return on investment in preventive care rarely aligns with the duration of an individual's enrollment in any single plan. The entity that pays for the prevention program is not guaranteed to be the entity that benefits from avoided hospitalizations or reduced chronic care costs down the line.
This structural gap has long frustrated healthcare economists and clinicians alike. When financial incentives do not reward prevention, the system defaults to managing illness after the fact — a reactive model that tends to be both more expensive and less effective at improving population health outcomes.
The question Greenfield raises is not merely academic. As healthcare costs continue to consume a growing share of household and government budgets, the debate over whether the system is truly investing in health — or simply paying for sickness — carries significant policy and financial implications. Continue reading at All Financial Services & Investing.